TY - JOUR
T1 - Therapy
T2 - Statins for secondary prevention: Might less in fact be more?
AU - Muñoz, Daniel
AU - Blumenthal, Roger S.
PY - 2011/3
Y1 - 2011/3
N2 - Statin therapy following myocardial infarction is a pillar of the secondary prevention approach. However, defining a maximally beneficial dosing strategy requires attention to both cardiovascular outcomes and to the potentially unsavory clinical adverse effects of high-dose therapy.
AB - Statin therapy following myocardial infarction is a pillar of the secondary prevention approach. However, defining a maximally beneficial dosing strategy requires attention to both cardiovascular outcomes and to the potentially unsavory clinical adverse effects of high-dose therapy.
UR - http://www.scopus.com/inward/record.url?scp=79952186744&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79952186744&partnerID=8YFLogxK
U2 - 10.1038/nrendo.2011.17
DO - 10.1038/nrendo.2011.17
M3 - Short survey
C2 - 21283125
AN - SCOPUS:79952186744
SN - 1759-5029
VL - 7
SP - 131
EP - 132
JO - Nature Reviews Endocrinology
JF - Nature Reviews Endocrinology
IS - 3
ER -